Duke suspends clinical trials After Scandal More padded Summary

Duke suspends clinical trials After Scandal More padded Summary -

Duke University has suspended three clinical cancer trials in response to allegations that a key researcher on embellished his resume studies.

The tumult
started last week when Letter cancer , Washington, DC, newsletter, reported that Anil Potti had apparently lied about being a Rhodes scholar and made other claims on unverifiable biographies included in its grant applications. Duke suspended Potti, and the American Cancer Society stopped payments on a grant. = "# sci-comment">

Today The New York Times reports that the Duke Sunday decided to stop enrollment in three clinical trials which Potti and Joseph Nevins Duke used gene expression signatures for predicting the response of a patient to chemotherapy. The university said it responded to the allegations concerning the powers and plans to review the research Potti.

In addition, the Times reports, more than two dozen researchers and cancer biostatistician expressed concerns about trials in a letter Monday to director Harold the National Cancer Institute Varmus. (The letter was also sent to the head of the Cancer Center at Duke, H. Kim Lyerly.) The letter reads in part: "Recently published and peer reviewed by the new analysis of the work of Potti and Nevins revealed serious errors which question the validity of predictive models on which these ongoing clinical trials are based. "

Tweet